Delhi HC quashes ban on FDC drugs

Advertisement
New Delhi: In a move that would bring great relief to pharmaceutical companies across the country, the Delhi High Court has set aside the government notification that called for a ban on 344 fixed dose combination (FDC) medicines.
The move, which would result in many popular medicines like Corex, Phensedyl, Saridon and Vicks Action 500 Extra hitting back the market shelves, came after the Delhi High court was found stating that the step of the government was taken in a "haphazard manner".
It is reported that on March 10th, government came out with an order banning said 344 FDC drugs, which included many popular brands of major pharmaceutical giants. The companies immediately knocked on the doors of the high court, challenging the government order
Justice Rajiv Sahai Endlaw allowed 454 petitions moved by various pharma and healthcare majors, like Pfizer, Glenmark, Procter and Gamble and Cipla, challenging the government's March 10 notification banning the FDCs, saying the decision was taken by the Centre without following procedure prescribed in the Drugs and Cosmetics Act.
The move, which would result in many popular medicines like Corex, Phensedyl, Saridon and Vicks Action 500 Extra hitting back the market shelves, came after the Delhi High court was found stating that the step of the government was taken in a "haphazard manner".
It is reported that on March 10th, government came out with an order banning said 344 FDC drugs, which included many popular brands of major pharmaceutical giants. The companies immediately knocked on the doors of the high court, challenging the government order
Justice Rajiv Sahai Endlaw allowed 454 petitions moved by various pharma and healthcare majors, like Pfizer, Glenmark, Procter and Gamble and Cipla, challenging the government's March 10 notification banning the FDCs, saying the decision was taken by the Centre without following procedure prescribed in the Drugs and Cosmetics Act.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.